Sunvozertinib is a chemical compound used as an active pharmaceutical ingredient. It is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor investigated for use in non-small-cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sunvozertinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Vanzacaftor
pharmaceutical raw material
Bexotegras
pharmaceutical raw material
Probenecid sodium
pharmaceutical raw material
Retatrutide
pharmaceutical raw material
The international HS code for Sunvozertinib (CAS 2370013-12-8) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide
BTMKEDDEMKKSEF-QGZVFWFLSA-N
CC(C)(C1=CC(=C(C=C1NC2=NC(=NC=C2)NC3=C(C=C(C(=C3)NC(=O)C=C)N4CC[C@H](C4)N(C)C)OC)Cl)F)O
Sourcing Sunvozertinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.